22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022

Go back to 22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Second Quarter 2022

Cowen on 22nd Century Group (XXII): 'GVB provides an attractive platform for XXII to build on its existing capabilities in cannabis'

August 9, 2022 4:43 PM EDT

Cowen analyst Vivien Azer reiterated an Outperform rating and $5.00 price target on 22nd Century Group (NASDAQ: XXII).

The analyst comments "GVB Acquisition Scales Cannabis Business. Revenue from hemp/cannabis related products in the 2Q22 was $4.5 mm, compared to $0 in the year ago... More

22nd Century Group (XXII) Reports In-Line Q2 EPS

August 9, 2022 6:09 AM EDT

22nd Century Group (NASDAQ: XXII) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $11.53 million.

For earnings history and earnings-related data on 22nd Century Group (XXII) click here.

... More